Dietary ketosis improves circadian dysfunction as well as motor symptoms in the BACHD mouse model of Huntington’s disease
Open Access
- 3 November 2022
- journal article
- research article
- Published by Frontiers Media SA in Frontiers in Nutrition
- Vol. 9, 1034743
Abstract
Disturbances in sleep/wake cycles are common among patients with neurodegenerative diseases including Huntington’s disease (HD) and represent an appealing target for chrono-nutrition-based interventions. In the present work, we sought to determine whether a low-carbohydrate, high-fat diet would ameliorate the symptoms and delay disease progression in the BACHD mouse model of HD. Adult WT and BACHD male mice were fed a normal or a ketogenic diet (KD) for 3 months. The KD evoked a robust rhythm in serum levels of β-hydroxybutyrate and dramatic changes in the microbiome of male WT and BACHD mice. NanoString analysis revealed transcriptional changes driven by the KD in the striatum of both WT and BACHD mice. Disturbances in sleep/wake cycles have been reported in mouse models of HD and are common among HD patients. Having established that the KD had effects on both the WT and mutant mice, we examined its impact on sleep/wake cycles. KD increased daytime sleep and improved the timing of sleep onset, while other sleep parameters were not altered. In addition, KD improved activity rhythms, including rhythmic power, and reduced inappropriate daytime activity and onset variability. Importantly, KD improved motor performance on the rotarod and challenging beam tests. It is worth emphasizing that HD is a genetically caused disease with no known cure. Life-style changes that not only improve the quality of life but also delay disease progression for HD patients are greatly needed. Our study demonstrates the therapeutic potential of diet-based treatment strategies in a pre-clinical model of HD.Keywords
Funding Information
- National Institute of Neurological Disorders and Stroke (NS115041)
- National Institute of Child Health and Human Development (5U54HD087101)
This publication has 90 references indexed in Scilit:
- The Q175 Mouse Model of Huntington’s Disease Shows Gene Dosage- and Age-Related Decline in Circadian Rhythms of Activity and SleepPLOS ONE, 2013
- Longitudinal analysis of the electroencephalogram and sleep phenotype in the R6/2 mouse model of Huntington’s diseaseBrain, 2013
- Progressive sleep and electroencephalogram changes in mice carrying the Huntington’s disease mutationBrain, 2013
- Circadian rhythms, sleep, and metabolismJournal of Clinical Investigation, 2011
- Dysfunctions in circadian behavior and physiology in mouse models of Huntington's diseaseExperimental Neurology, 2011
- Circadian Integration of Metabolism and EnergeticsScience, 2010
- Amyloid-β Dynamics Are Regulated by Orexin and the Sleep-Wake CycleScience, 2009
- Full-Length Human Mutant Huntingtin with a Stable Polyglutamine Repeat Can Elicit Progressive and Selective Neuropathogenesis in BACHD MiceThe Journal of Neuroscience, 2008
- Homer1a is a core brain molecular correlate of sleep lossProceedings of the National Academy of Sciences, 2007
- Pharmacological Imposition of Sleep Slows Cognitive Decline and Reverses Dysregulation of Circadian Gene Expression in a Transgenic Mouse Model of Huntington's DiseaseJournal of Neuroscience, 2007